Skip to main content
Figure 1 | Genome Medicine

Figure 1

From: Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling

Figure 1

Identification and quantitative analysis of peptides in plasma. From CHD cases and controls in eight experiments for (a) beta-2 microglobulin (B2M) and (b) alpha-1-acid glycoprotein 1 (ORM1); and from stroke cases and controls in eight experiments for (c) peptidyl-prolyl isomerase A (PPIA) and (d) insulin-like growth factor binding protein 4 (IGFBP4). Tryptic peptides from the amino terminus (1) to the carboxyl terminus are shown at the top. S, C and G indicate signal peptide, cysteine-containing and glycosylated peptides, respectively. Peptides identified, but which lack cysteine for quantification, are shown in gray. The log2 case/control ratio is shown for cysteine-containing peptides with the number of MS events for that peptide shown in parentheses. The number of plasma fractions where each peptide was quantified is indicated.

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us